HighTower Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $202M | Sell |
1,450,177
-211,178
| -13% | -$29.6M | 0.21% | 96 |
|
|
2025
Q4 | $204M | Sell |
1,661,355
-14,442
| -0.9% | -$1.76M | 0.22% | 96 |
|
|
2025
Q3 | $186M | Buy |
1,675,797
+13,374
| +0.8% | +$1.52M | 0.21% | 105 |
|
|
2025
Q2 | $184M | Sell |
1,662,423
-39,987
| -2% | -$4.26M | 0.23% | 91 |
|
|
2025
Q1 | $191M | Sell |
1,702,410
-91,289
| -5% | -$9.42M | 0.26% | 79 |
|
|
2024
Q4 | $166M | Buy |
1,793,699
+12,746
| +0.7% | +$1.15M | 0.23% | 97 |
|
|
2024
Q3 | $149M | Buy |
1,780,953
+155,023
| +10% | +$11.8M | 0.21% | 104 |
|
|
2024
Q2 | $112M | Buy |
1,625,930
+268,032
| +20% | +$17.9M | 0.17% | 133 |
|
|
2024
Q1 | $99.5M | Buy |
1,357,898
+149,560
| +12% | +$11.5M | 0.16% | 146 |
|
|
2023
Q4 | $97.9M | Buy |
1,208,338
+39,212
| +3% | +$3.05M | 0.16% | 134 |
|
|
2023
Q3 | $87.6M | Buy |
1,169,126
+77,653
| +7% | +$5.97M | 0.16% | 136 |
|
|
2023
Q2 | $84.1M | Buy |
1,091,473
+31,599
| +3% | +$2.52M | 0.17% | 130 |
|
|
2023
Q1 | $87.9M | Sell |
1,059,874
-264,803
| -20% | -$21.9M | 0.19% | 114 |
|
|
2022
Q4 | $114M | Buy |
1,324,677
+196,260
| +17% | +$15.5M | 0.26% | 83 |
|
|
2022
Q3 | $69.6M | Buy |
1,128,417
+57,949
| +5% | +$3.65M | 0.19% | 119 |
|
|
2022
Q2 | $66.1M | Buy |
1,070,468
+104,664
| +11% | +$6.48M | 0.17% | 130 |
|
|
2022
Q1 | $57.4M | Buy |
965,804
+80,969
| +9% | +$5.18M | 0.13% | 163 |
|
|
2021
Q4 | $64.2M | Buy |
884,835
+52,755
| +6% | +$3.63M | 0.14% | 159 |
|
|
2021
Q3 | $58.1M | Buy |
832,080
+50,703
| +6% | +$3.56M | 0.16% | 139 |
|
|
2021
Q2 | $53.8M | Buy |
781,377
+56,845
| +8% | +$3.8M | 0.16% | 140 |
|
|
2021
Q1 | $46.8M | Buy |
724,532
+147,189
| +25% | +$9.49M | 0.15% | 147 |
|
|
2020
Q4 | $33.7M | Sell |
577,343
-118,811
| -17% | -$7.17M | 0.14% | 145 |
|
|
2020
Q3 | $44M | Buy |
696,154
+69,814
| +11% | +$4.84M | 0.21% | 102 |
|
|
2020
Q2 | $48.3M | Buy |
626,340
+36,965
| +6% | +$2.83M | 0.26% | 82 |
|
|
2020
Q1 | $44M | Buy |
589,375
+61,107
| +12% | +$4.22M | 0.29% | 73 |
|
|
2019
Q4 | $34.3M | Buy |
528,268
+107,761
| +26% | +$7.02M | 0.2% | 107 |
|
|
2019
Q3 | $26.7M | Buy |
420,507
+11,890
| +3% | +$777K | 0.15% | 150 |
|
|
2019
Q2 | $27.6M | Buy |
408,617
+28,263
| +7% | +$1.86M | 0.16% | 135 |
|
|
2019
Q1 | $24.8M | Sell |
380,354
-14,427
| -4% | -$959K | 0.17% | 133 |
|
|
2018
Q4 | $24.8M | Sell |
394,781
-56,659
| -13% | -$3.96M | 0.19% | 115 |
|
|
2018
Q3 | $34.9M | Buy |
451,440
+51,400
| +13% | +$3.88M | 0.25% | 86 |
|
|
2018
Q2 | $28.3M | Sell |
400,040
-5,537
| -1% | -$391K | 0.22% | 93 |
|
|
2018
Q1 | $30.6M | Sell |
405,577
-21,355
| -5% | -$1.7M | 0.26% | 83 |
|
|
2017
Q4 | $30.6M | Sell |
426,932
-49,458
| -10% | -$3.76M | 0.25% | 87 |
|
|
2017
Q3 | $38.6M | Buy |
476,390
+114,730
| +32% | +$8.77M | 0.33% | 60 |
|
|
2017
Q2 | $25.6M | Buy |
361,660
+6,746
| +2% | +$449K | 0.23% | 89 |
|
|
2017
Q1 | $24.1M | Buy |
354,914
+86,246
| +32% | +$6.06M | 0.23% | 91 |
|
|
2016
Q4 | $19.3M | Sell |
268,668
-43,147
| -14% | -$3.21M | 0.21% | 96 |
|
|
2016
Q3 | $24.7M | Buy |
311,815
+14,359
| +5% | +$1.17M | 0.29% | 73 |
|
|
2016
Q2 | $24.9M | Sell |
297,456
-20,727
| -7% | -$1.84M | 0.31% | 68 |
|
|
2016
Q1 | $29.3M | Sell |
318,183
-36,077
| -10% | -$3.25M | 0.1% | 67 |
|
|
2015
Q4 | $35.8M | Buy |
354,260
+2,798
| +0.8% | +$291K | 0.43% | 44 |
|
|
2015
Q3 | $34.5M | Buy |
351,462
+38,700
| +12% | +$4.3M | 0.46% | 37 |
|
|
2015
Q2 | $36.6M | Buy |
312,762
+63,532
| +25% | +$6.94M | 0.59% | 29 |
|
|
2015
Q1 | $24.5M | Buy |
249,230
+58,609
| +31% | +$5.95M | 0.36% | 55 |
|
|
2014
Q4 | $18M | Buy |
190,621
+10,687
| +6% | +$1.11M | 0.28% | 80 |
|
|
2014
Q3 | $19.1M | Sell |
179,934
-11,550
| -6% | -$1.13M | 0.32% | 63 |
|
|
2014
Q2 | $15.9M | Buy |
191,484
+22,972
| +14% | +$1.79M | 0.28% | 72 |
|
|
2014
Q1 | $10.7M | Sell |
168,512
-57,887
| -26% | -$4.54M | 0.21% | 108 |
|
|
2013
Q4 | $17M | Buy |
226,399
+9,252
| +4% | +$644K | 0.35% | 56 |
|
|
2013
Q3 | $13.7M | Buy |
217,147
+10,871
| +5% | +$650K | 0.34% | 62 |
|
|
2013
Q2 | $10.6M | Buy |
+206,276
| New | +$10.8M | 0.29% | 75 |
|
Other funds holding GILD
VCM
VPM
HighTower Advisors's GILD Position: Q1 2026 in Review
HighTower Advisors reduced its Gilead Sciences (GILD) stake by 13% in Q1 2026, selling an estimated $29.6M and leaving 1,450,177 shares worth $202M. The position accounts for 0.21% of the portfolio, ranked #96.
HighTower Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $204M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- HighTower Advisors held 1,450,177 shares of Gilead Sciences worth $202M as of Q1 2026.
- HighTower Advisors sold 211,178 Gilead Sciences shares in Q1 2026, an estimated $29.6M.
- Gilead Sciences made up 0.21% of HighTower Advisors's portfolio in Q1 2026, its #96 holding.
- HighTower Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- HighTower Advisors's Gilead Sciences position peaked at $204M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.